An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Under normal market conditions, the fund invests at least 80% of its net assets in instruments with economic characteristics similar to securities of companies with growth characteristics.
read at $25.89
AllianzIM Growth-100 Buffer15 ETF holds its Markup at $25.89.
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Price | $25.89 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | N/A |
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $25.80 | +0.3% | · | $1,003 | +0.3% |
| 2 months | $25.40 | +1.9% | · | $1,019 | +1.9% |
Historical returns from market close data. Past performance does not guarantee future results.
Get our weekly market brief free.